The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies

Michihiko Kuwano, Takeshi Uchiumi, Hiroshi Hayakawa, Mayumi Ono, Morimasa Wada, Hiroto Izumi, Kimitoshi Kohno

Research output: Contribution to journalReview article

Abstract

In our laboratories, we have been studying molecular targets which might be advantageous for novel cancer therapeutics. In this review, we focus on how ATP-binding cassette (ABC) transporter superfamily genes, Y-box-binding protein-1 (YB-1), and tumor angiogenesis-associated factors could contribute to the development of novel strategies for molecular cancer therapeutics. ABC transporters such as P-glycoprotein/MDR1 and several MRP family proteins function to protect cells from xenobiotics, drugs and poisons, suggesting that ABC transporters are a double-edged sword. In this regard, P-glycoprotein/MDR1 is a representative ABC transporter which plays a critical role in the efflux of a wide range of drugs. We have reported that gene amplification, gene rearrangements, transcription factor YB-1 and CpG methylation on the promoter are involved in MDR1 gene overexpression in cultured cancer cells. Among them, two mechanisms appear to be relevant to the up-regulation of MDR1 gene in human malignancies. We first reported that MDR1 gene promoter is activated in response to environmental stimuli, and is modulated by methylation/demethylation of CpG sites on the MDR1 promoter. We also demonstrated that YB-1 modulates not only transcription of various genes associated with cell growth, drug resistance and DNA synthesis, but also translation, mRNA stabilization and DNA repair/self-defense processes. Angiogenesis is also involved in tumor growth, invasion and metastasis of various malignancies, and so angiogenesis-related molecules also offer novel molecular targets for anticancer therapeutics.

Original languageEnglish
Pages (from-to)247-259
Number of pages13
JournalGann Monographs on Cancer Research
Volume52
Publication statusPublished - Jul 1 2004

Fingerprint

Y-Box-Binding Protein 1
ATP-Binding Cassette Transporters
Angiogenesis Inducing Agents
Neoplasms
Genes
P-Glycoprotein
Methylation
Gene Rearrangement
Gene Amplification
Poisons
Protein Biosynthesis
Xenobiotics
Growth
Drug Resistance
DNA Repair
Pharmaceutical Preparations
Cultured Cells
Transcription Factors
Up-Regulation
Therapeutics

All Science Journal Classification (ASJC) codes

  • Cancer Research

Cite this

The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies. / Kuwano, Michihiko; Uchiumi, Takeshi; Hayakawa, Hiroshi; Ono, Mayumi; Wada, Morimasa; Izumi, Hiroto; Kohno, Kimitoshi.

In: Gann Monographs on Cancer Research, Vol. 52, 01.07.2004, p. 247-259.

Research output: Contribution to journalReview article

Kuwano, Michihiko ; Uchiumi, Takeshi ; Hayakawa, Hiroshi ; Ono, Mayumi ; Wada, Morimasa ; Izumi, Hiroto ; Kohno, Kimitoshi. / The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies. In: Gann Monographs on Cancer Research. 2004 ; Vol. 52. pp. 247-259.
@article{9d710e2c9eb74437aecde50e1862bda3,
title = "The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies",
abstract = "In our laboratories, we have been studying molecular targets which might be advantageous for novel cancer therapeutics. In this review, we focus on how ATP-binding cassette (ABC) transporter superfamily genes, Y-box-binding protein-1 (YB-1), and tumor angiogenesis-associated factors could contribute to the development of novel strategies for molecular cancer therapeutics. ABC transporters such as P-glycoprotein/MDR1 and several MRP family proteins function to protect cells from xenobiotics, drugs and poisons, suggesting that ABC transporters are a double-edged sword. In this regard, P-glycoprotein/MDR1 is a representative ABC transporter which plays a critical role in the efflux of a wide range of drugs. We have reported that gene amplification, gene rearrangements, transcription factor YB-1 and CpG methylation on the promoter are involved in MDR1 gene overexpression in cultured cancer cells. Among them, two mechanisms appear to be relevant to the up-regulation of MDR1 gene in human malignancies. We first reported that MDR1 gene promoter is activated in response to environmental stimuli, and is modulated by methylation/demethylation of CpG sites on the MDR1 promoter. We also demonstrated that YB-1 modulates not only transcription of various genes associated with cell growth, drug resistance and DNA synthesis, but also translation, mRNA stabilization and DNA repair/self-defense processes. Angiogenesis is also involved in tumor growth, invasion and metastasis of various malignancies, and so angiogenesis-related molecules also offer novel molecular targets for anticancer therapeutics.",
author = "Michihiko Kuwano and Takeshi Uchiumi and Hiroshi Hayakawa and Mayumi Ono and Morimasa Wada and Hiroto Izumi and Kimitoshi Kohno",
year = "2004",
month = "7",
day = "1",
language = "English",
volume = "52",
pages = "247--259",
journal = "Gann Monographs on Cancer Research",
issn = "0072-0151",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies

AU - Kuwano, Michihiko

AU - Uchiumi, Takeshi

AU - Hayakawa, Hiroshi

AU - Ono, Mayumi

AU - Wada, Morimasa

AU - Izumi, Hiroto

AU - Kohno, Kimitoshi

PY - 2004/7/1

Y1 - 2004/7/1

N2 - In our laboratories, we have been studying molecular targets which might be advantageous for novel cancer therapeutics. In this review, we focus on how ATP-binding cassette (ABC) transporter superfamily genes, Y-box-binding protein-1 (YB-1), and tumor angiogenesis-associated factors could contribute to the development of novel strategies for molecular cancer therapeutics. ABC transporters such as P-glycoprotein/MDR1 and several MRP family proteins function to protect cells from xenobiotics, drugs and poisons, suggesting that ABC transporters are a double-edged sword. In this regard, P-glycoprotein/MDR1 is a representative ABC transporter which plays a critical role in the efflux of a wide range of drugs. We have reported that gene amplification, gene rearrangements, transcription factor YB-1 and CpG methylation on the promoter are involved in MDR1 gene overexpression in cultured cancer cells. Among them, two mechanisms appear to be relevant to the up-regulation of MDR1 gene in human malignancies. We first reported that MDR1 gene promoter is activated in response to environmental stimuli, and is modulated by methylation/demethylation of CpG sites on the MDR1 promoter. We also demonstrated that YB-1 modulates not only transcription of various genes associated with cell growth, drug resistance and DNA synthesis, but also translation, mRNA stabilization and DNA repair/self-defense processes. Angiogenesis is also involved in tumor growth, invasion and metastasis of various malignancies, and so angiogenesis-related molecules also offer novel molecular targets for anticancer therapeutics.

AB - In our laboratories, we have been studying molecular targets which might be advantageous for novel cancer therapeutics. In this review, we focus on how ATP-binding cassette (ABC) transporter superfamily genes, Y-box-binding protein-1 (YB-1), and tumor angiogenesis-associated factors could contribute to the development of novel strategies for molecular cancer therapeutics. ABC transporters such as P-glycoprotein/MDR1 and several MRP family proteins function to protect cells from xenobiotics, drugs and poisons, suggesting that ABC transporters are a double-edged sword. In this regard, P-glycoprotein/MDR1 is a representative ABC transporter which plays a critical role in the efflux of a wide range of drugs. We have reported that gene amplification, gene rearrangements, transcription factor YB-1 and CpG methylation on the promoter are involved in MDR1 gene overexpression in cultured cancer cells. Among them, two mechanisms appear to be relevant to the up-regulation of MDR1 gene in human malignancies. We first reported that MDR1 gene promoter is activated in response to environmental stimuli, and is modulated by methylation/demethylation of CpG sites on the MDR1 promoter. We also demonstrated that YB-1 modulates not only transcription of various genes associated with cell growth, drug resistance and DNA synthesis, but also translation, mRNA stabilization and DNA repair/self-defense processes. Angiogenesis is also involved in tumor growth, invasion and metastasis of various malignancies, and so angiogenesis-related molecules also offer novel molecular targets for anticancer therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=24144464516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24144464516&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:24144464516

VL - 52

SP - 247

EP - 259

JO - Gann Monographs on Cancer Research

JF - Gann Monographs on Cancer Research

SN - 0072-0151

ER -